基于纵向MR弹性成像评估慢性丙型肝炎病毒感染患者的长期临床结局与短期疗效
研究纳入159名成人,回顾性分析138例至少两次2D MRE的HCV患者,定义LS较基线升高≥19%为进展,评估LSB及LSB联合ΔLS对肝脏相关事件的预测价值;同时前瞻性分析21人(11例接受DAA治疗、10例健康对照),用双频3D MRE比较治疗期间五个时间点的LS、LM和DR。结果显示LSB每增加1 kPa,LRE风险翻倍(aHR=2.05),联合ΔLS预测性能更优(aHR=2.92);进展者肝硬化HR为15.44;DAA治疗后LS下降,LM先升高后12个月恢复正常。
要点
- 纵向2D MRE的LS变化可预测HCV患者未来肝脏相关事件,联合LSB与ΔLS风险分层优于单用LS。
- LSB每增加1 kPa,LRE风险翻倍(aHR=2.05,C-statistic=0.831,p<0.001)。
- 进展者(ΔLS≥19%)发生肝硬化的HR为15.44(p<0.001)。
核心结论
- 2D MRE评估的纵向LS变化可预测HCV患者未来临床事件,风险分层优于单独LS。
- 多参数双频3D MRE有望用于短期疗效监测,DAA治疗后LS下降、LM先升高后12个月恢复正常。
研究设计与样本
- 回顾性分析138例至少两次2D MRE的HCV参与者,定义进展为LS较基线升高ΔLS≥19%。
- 前瞻性分析21人,其中11例接受DAA治疗、10例健康对照,采用双频3D MRE在治疗期间五个时间点比较LS、LM和DR。
关键影像表现/征象
- 138例HCV中38例(27.5%)为进展者,ΔLS=0.393 kPa/年;11例发生LREs,其ΔLS上升更陡(0.614 kPa/年)。
- 进展者发生肝硬化的HR为15.44(p<0.001)。
- DAA治疗后LS下降,LM初期升高(p<0.05),至治疗后12个月恢复正常。
诊断标准与关键数值
- 进展定义为LS较基线升高ΔLS≥19%。
- LSB每增加1 kPa与LRE风险翻倍相关(aHR=2.05;C-statistic=0.831,p<0.001)。
- LSB联合ΔLS预测LRE的aHR=2.92,C-statistic=0.883,p<0.001。
临床应用与阅片要点
- 纵向MRE可作为慢性肝病的可靠随访工具,用于结局预测、风险分层和治疗监测。
- 多参数双频3D MRE可检测短期炎症和治疗相关变化,增强疾病监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Magnetic resonance elastography (MRE) provides multiple quantitative biomarkers for assessing chronic liver disease. This study evaluated the prognostic value of MRE-based long-term liver stiffness (LS) changes in chronic hepatitis C virus (HCV) infection and explored short-term viscosity changes (loss modulus, LM) for monitoring responses to direct-acting antiviral treatment (DAA-Tx).
MATERIALS AND METHODS: One hundred fifty-nine adults were included. We retrospectively analyzed 138 HCV participants with at least two 2D MREs, defining progression as an LS increase ΔLS ≥ 19% above baseline (LSB), predicting liver-related events (LREs) with Kaplan-Meier plots and Cox proportional hazards regression. We also prospectively analyzed 21 participants, 11 of whom underwent DAA-Tx and ten healthy controls. Dual-frequency 3D MRE-derived LS, LM, and damping ratio (DR) were compared at five time points during DAA-Tx.
RESULTS: Among the 138 HCVs, 38 (27.5%) were progressors, with a ΔLS = 0.393 kPa/year; 11 developed LREs, showing a steeper rise of 0.614 kPa/year. LSB and the combination of LSB and ΔLS were significantly associated with LREs. Specifically, each 1 kPa increase in LSB was associated with doubled risk of developing LREs [adjusted hazard ratio (aHR) = 2.05; C-statistic = 0.831, p < 0.001]. The combination of LSB and ΔLS further improved predictive performance (aHR = 2.92; C-statistic = 0.883, p < 0.001). Progressors had a hazard ratio (HR) of 15.44 for developing cirrhosis (p < 0.001). LS decreased post-DAA-Tx, while LM initially increased (p < 0.05) and normalized by 12 months post-DAA-Tx.
CONCLUSIONS: Two-dimensional MRE-assessed longitudinal change in LS can predict future clinical events in HCV patients, providing better risk stratification than LS alone. Multiparametric dual-frequency 3D MRE has promise for short-term changes in treatment effects.
KEY POINTS: Question Accurately predicting clinical outcomes and monitoring direct-acting antiviral (DAA) treatment efficacy in HCV patients remains an unmet need. Findings Longitudinal LS changes predict future clinical events in HCV patients. Multiparametric dual-frequency 3D MRE detects short-term inflammatory and treatment-related changes, enhancing disease monitoring. Clinical relevance This study demonstrates longitudinal MRE as a reliable follow-up tool for chronic liver disease, enabling outcome prediction, risk stratification, and treatment monitoring, advancing personalized, non-invasive management for HCV patients.
引用
- Qiu C, Wu H, Xu P, et al. Long-term clinical outcomes and short-term treatment efficacy evaluation based on longitudinal MR elastography in patients with chronic hepatitis C virus infection. Eur Radiol. 2025. PMID: 40760117. doi:10.1007/s00330-025-11905-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。